The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health.

ABSTRACT:

Background

Metabolic Syndrome, or Syndrome X, is characterized by a set of metabolic and lipid imbalances that greatly increases the risk of developing diabetes and cardiovascular disease. The syndrome is highly prevalent in the United States and worldwide, and treatments are in high demand. ProAlgaZyme, a novel and proprietary freshwater algae infusion in purified water, has been the subject of several animal studies and has demonstrated low toxicity even with chronic administration at elevated doses. The infusion has been used historically for the treatment of several inflammatory and immune disorders in humans and is considered well-tolerated. Here, the infusion is evaluated for its effects on the cardiovascular risk factors present in metabolic syndrome in a randomized double-b

SUBMITTER: Oben J 

PROVIDER: S-EPMC2034560 | biostudies-literature | 2007 Sep

REPOSITORIES: biostudies-literature